@article{20b1147eebd3492a89f05e4e520fb42f,
title = "Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping",
author = "Roberto Badagliacca and Silvia Papa and Franz Rischard",
note = "Funding Information: The Pulmonary Vascular Phenomics project funded by the National Heart Lung and Blood Institute and the Pulmonary Hypertension Association in the United States may further elucidate the unknowns in pulmonary hypertension classification. This project aims to use deep phenotyping to investigate disease mechanisms across all World Symposium on Pulmonary Hypertension groups, including IPAH. This project employs provocative maneuvers including fluid loading and invasive cardiopulmonary exercise testing, among others, as well as advanced RV imaging and omic analysis. 18 Funding Information: F.R. has received research grants from Actelion, Bayer, United Therapeutics, Phase Bio, Acceleron, and NHLBI of the NIH. R.B. reports personal fees from United Therapeutics, Domp{\`e}, Ferrer, Bayer, Merck Sharp & Dohme, and AOP Orphan Pharmaceuticals AG, outside of the submitted work. The remaining authors have no conflicts of interest to disclose.",
year = "2021",
month = feb,
doi = "10.1016/j.healun.2020.11.001",
language = "English (US)",
volume = "40",
pages = "166--167",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "2",
}